| 000 | 01908 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250515122811.0 | ||
| 264 | 0 | _c20090204 | |
| 008 | 200902s 0 0 eng d | ||
| 022 | _a1536-4844 | ||
| 024 | 7 |
_a10.1002/ibd.20509 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aEfthymiou, Alkiviadis | |
| 245 | 0 | 0 |
_aDoes clinical response correlate with mucosal healing in patients with Crohn's disease of the small bowel? A prospective, case-series study using wireless capsule endoscopy. _h[electronic resource] |
| 260 |
_bInflammatory bowel diseases _cNov 2008 |
||
| 300 |
_a1542-7 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Multicenter Study | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAnti-Infective Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xtherapeutic use |
| 650 | 0 | 4 |
_aAzathioprine _xtherapeutic use |
| 650 | 0 | 4 | _aCapsule Endoscopy |
| 650 | 0 | 4 | _aCohort Studies |
| 650 | 0 | 4 |
_aCrohn Disease _xdrug therapy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xtherapeutic use |
| 650 | 0 | 4 | _aInfliximab |
| 650 | 0 | 4 |
_aIntestinal Mucosa _xdrug effects |
| 650 | 0 | 4 |
_aIntestine, Small _xdrug effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMetronidazole _xtherapeutic use |
| 650 | 0 | 4 |
_aPrednisolone _xtherapeutic use |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aQuality of Life |
| 650 | 0 | 4 | _aRisk Assessment |
| 650 | 0 | 4 | _aSeverity of Illness Index |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aViazis, Nikos | |
| 700 | 1 | _aMantzaris, Gerassimos | |
| 700 | 1 | _aPapadimitriou, Nikos | |
| 700 | 1 | _aTzourmakliotis, Dimitrios | |
| 700 | 1 | _aRaptis, Sotirios | |
| 700 | 1 | _aKaramanolis, Dimitrios G | |
| 773 | 0 |
_tInflammatory bowel diseases _gvol. 14 _gno. 11 _gp. 1542-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/ibd.20509 _zAvailable from publisher's website |
| 999 |
_c18014628 _d18014628 |
||